Dunlop and colleagues1 provide valuable insights into the use of e-cigarettes and their potential for improving public health.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
Responses are now closed for this article.
I have received payments for teaching, consulting and conference expenses from Pfizer Australia, GlaxoSmithKline Australia and Johnson and Johnson Pacific. I have no commercial or other relationship with any tobacco or e-cigarette companies.